Case Report: CD19 and CD20 monoclonal antibodies with sequential chemotherapy for refractory acute B-lymphocytic leukemia in children.

MLA

Jia-Nan Li, et al. “Case Report: CD19 and CD20 Monoclonal Antibodies with Sequential Chemotherapy for Refractory Acute B-Lymphocytic Leukemia in Children.” Frontiers in Immunology, Dec. 2023, pp. 1–14. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1280759.

APA

Jia-Nan Li, Yu Li, Ji-Xun Lin, Li-Na Wang, Xiao-Li Zhang, Juan Ouyang, Du-Bo Chen, Shao-Qian Chen, Jun-Xun Li, Xue-Qun Luo, Yan-Lai Tang, & Li-Bin Huang. (2023). Case Report: CD19 and CD20 monoclonal antibodies with sequential chemotherapy for refractory acute B-lymphocytic leukemia in children. Frontiers in Immunology, 1–14. https://doi.org/10.3389/fimmu.2023.1280759

Chicago

Jia-Nan Li, Yu Li, Ji-Xun Lin, Li-Na Wang, Xiao-Li Zhang, Juan Ouyang, Du-Bo Chen, et al. 2023. “Case Report: CD19 and CD20 Monoclonal Antibodies with Sequential Chemotherapy for Refractory Acute B-Lymphocytic Leukemia in Children.” Frontiers in Immunology, December, 1–14. doi:10.3389/fimmu.2023.1280759.